Author:
Dagur Raghubendra Singh,Hambarde Shashank,Chandna Sudhir
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Reference48 articles.
1. Berkow RL, Kraft AS (1985) Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor. Biochem Biophys Res Commun 131:1109–1116. doi: 10.1016/0006-291X(85)90205-0
2. Sivak A, Ray F, Van Duuren BL (1969) Phorbol ester tumor-promoting agents and membrane stability. Cancer Res 29:624–630
3. Philip PA, Zonder JA (1999) Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug. Expert Opin Investig Drugs 8:2189–2199. doi: 10.1517/13543784.8.12.2189
4. Isakov N, Galron D, Mustelin T, Pettit GR, Altman A (1993) Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. J Immunol 150:1195–1204
5. Jarvis WD, Povirk LF, Turner AJ, Traylor RS, Gewirtz DA, Pettit GR, Grant S (1994) Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochem Pharmacol 47:839–852
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献